Proportions of blood-borne Vd1þ and Vd2þ T-cells are associated with overall survival of melanoma patients treated with ipilimumab
Wistuba-Hamprecht, Kilian U, Martens, Alexander U, Haehnel, Karin U, Geukes Foppen, Marnix A, Yuan, Jianda U, Postow, Michael U, Wong, Phillip U, Romano, Emanuela U, Khammari, Amir U, Dréno, Brigitte, Capone, Mariaelena, Ascierto, Paolo A, Demuth, Ilja U, Steinhagen-Thiessen, Elisabeth U, Larbi, Anis A, Schilling, Bastian U, Schadendorf, Dirk U, Wolchok, Jedd U, Blank, Christian U, Pawelec, Graham U, Garbe, Claus U, Weide, Benjamin U
Published in European journal of cancer (1990) (01.09.2016)
Published in European journal of cancer (1990) (01.09.2016)
Get full text
Journal Article